Phase II Dasatinib Study in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dasatinib
Related studies linked through entity extraction aliases.
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dasatinib in Polycythemia Vera
- Status
- TERMINATED
- Phase
- PHASE2
Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE1
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Dasatinib in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Dasatinib in Advanced Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access for Dasatinib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2